0001055726-22-000001.txt : 20220105
0001055726-22-000001.hdr.sgml : 20220105
20220105160405
ACCESSION NUMBER: 0001055726-22-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220103
FILED AS OF DATE: 20220105
DATE AS OF CHANGE: 20220105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zoth Lota S.
CENTRAL INDEX KEY: 0001278219
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14888
FILM NUMBER: 22511084
MAIL ADDRESS:
STREET 1: 334 CR 692
CITY: BUFFALO GAP
STATE: TX
ZIP: 79508
FORMER NAME:
FORMER CONFORMED NAME: ZOTH LOTA S
DATE OF NAME CHANGE: 20040130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INOVIO PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001055726
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330969592
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6769 MESA RIDGE RD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8584103134
MAIL ADDRESS:
STREET 1: 6769 MESA RIDGE RD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: INOVIO BIOMEDICAL CORP
DATE OF NAME CHANGE: 20050404
FORMER COMPANY:
FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL CORP
DATE OF NAME CHANGE: 20011116
FORMER COMPANY:
FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL LTD
DATE OF NAME CHANGE: 19980213
4
1
wf-form4_164141662488992.xml
FORM 4
X0306
4
2022-01-03
0
0001055726
INOVIO PHARMACEUTICALS, INC.
INO
0001278219
Zoth Lota S.
660 W. GERMANTOWN PIKE
SUITE 110
PLYMOUTH MEETING
PA
19462
1
0
0
0
Common Stock
2022-01-03
4
M
0
4090
A
25977
D
Common Stock
2022-01-05
4
S
0
961
5.01
D
25016
D
Restricted Stock Unit
2022-01-03
4
M
0
4090
0
D
Common Stock
4090.0
0
D
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 12,270 restricted stock units is as follows: 4,090 shares vested on January 3, 2020; 4,090 shares vested on January 3, 2021; 4,090 shares vested on January 3, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
/s/ Lota Zoth
2022-01-05